HCW Biologics Q1 EPS $(0.20) Down From $(0.14) YoY, Sales $1.13M Up From $41.88K YoY
Portfolio Pulse from Benzinga Newsdesk
HCW Biologics (NASDAQ:HCWB) reported a Q1 EPS of $(0.20), a 42.86% decrease from $(0.14) YoY, and sales of $1.13M, a 2.59K% increase from $41.88K YoY.
May 15, 2024 | 9:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
HCW Biologics reported a significant increase in sales to $1.13M, up 2.59K% YoY, but also a larger loss per share of $(0.20), down 42.86% YoY.
While the significant increase in sales is a positive indicator, the larger loss per share may concern investors. The mixed results could lead to a neutral short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100